Point-of-care and EHR media for pharma

Waiting-Room Media: Programmatic vs. Location-Direct Buys

Waiting-room and exam-room media for pharma: programmatic vs location-direct buys, how to compare costs, and how to measure patient impact.

Christian Guerrero Published 3 min read Part 5 of 10

The short answer

Waiting-room media can be bought directly from point-of-care networks that place screens and content in practices, or programmatically through digital out-of-home platforms that include some healthcare venues. Programmatic can be cheaper per impression and more flexible, but often offers less control over which practices run the ad. Direct buys cost more but let you choose target practices, specialties, and content formats, which usually matters more for pharma.

Patients in a waiting room are thinking about their health and are about to talk to a clinician. That makes waiting and exam room media attractive for DTC brands. The buying choice is between going direct to a point-of-care network or buying screens through programmatic digital out-of-home.

The two buying routes

Location-direct (point-of-care network) Programmatic DOOH
Inventory Screens, tablets, print in practices the network partners with Healthcare venues within broader DOOH supply
Practice selection Often by specialty, practice, or target list Often by venue category and geography
Formats Video loops, interactive tablets, wallboards, print Mainly screen ads
Pricing Sponsorship, location, or guaranteed delivery CPM, auction or deals
Flexibility Committed flights Start, stop, shift quickly
Reporting Location and content reports; outcome studies offered Impression estimates by venue

Which is cheaper?

Programmatic DOOH often has a lower cost per estimated impression. But compare the right unit: cost per target practice reached, or per patient visit in the relevant specialty.

Hypothetical example. A dermatology brand wants dermatology waiting rooms.

  • Direct network: 1,200 dermatology practices, all on the target list. Higher fee.
  • Programmatic DOOH: lower CPM across "medical offices" in chosen cities. Only some screens are in dermatology practices.

If a fifth of the programmatic impressions land in dermatology practices, the effective cost per relevant impression may be higher than the direct buy.

When direct makes sense

  • You need specific specialties or practices.
  • You want interactive or exam room formats.
  • You need practice-level data for outcome measurement.
  • Content requires review of each placement.

When programmatic makes sense

  • Broad health audiences are acceptable, such as a common condition.
  • You want to test quickly or flex budget.
  • You are combining healthcare venues with pharmacies or retail DOOH.

The audio and DOOH article covers programmatic DOOH more broadly.

Content rules

Branded content in waiting rooms is consumer-directed promotion. It must present risk information appropriately. Many screens run without sound, which affects how risk information is shown. Unbranded condition education is common and simpler to approve.

Measurement

Measure at the practice level:

  • Delivery. Which practices ran the content and for how long.
  • Patient actions. Questions asked, brochure pickups, QR scans (signals only).
  • Outcomes. New prescriptions from exposed practices versus matched unexposed practices.

See point-of-care KPIs.

Questions to ask

  1. How many practices on my target list do you cover?
  2. How is audience estimated?
  3. How often does my content run in each loop?
  4. Can you provide practice-level delivery for an outcome study?
  5. What are the content and sound constraints?

Common mistakes

  • Comparing CPMs without checking venue relevance.
  • Assuming every "medical office" screen reaches your patients.
  • Branded content that fails without sound.
  • No practice-level data for measurement.

Practical takeaway

Ask both a direct network and a programmatic DOOH platform to show how many impressions would land in practices on your target list. Compare cost on that basis, not on headline CPM.

Frequently asked questions

Is waiting-room advertising effective for pharma?

It can be, especially for prompting patients to ask about a condition or treatment during the visit. Effect should be measured with outcome studies comparing exposed and similar unexposed practices.

Can waiting-room screens be bought programmatically?

Some can, through digital out-of-home platforms. Coverage of medical venues and the ability to choose specific practices vary.

What content works on waiting-room screens?

Short, clear condition education and prompts to talk to the doctor. Branded ads must include required risk information in a form that works without sound in many settings.

Sources

External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.

Working through this decision on a real plan?

I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.